
You can purchase shares of TuHURA Biosciences (NASDAQ:HURA) through any online brokerage.
Other companies in TuHURA Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
TuHURA Biosciences has a consensus price target of $9.50.
The stock price for TuHURA Biosciences (NASDAQ: HURA) is $1.5 last updated November 12, 2026 at 7:44 PM EST.
There are no upcoming dividends for TuHURA Biosciences.
TuHURA Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for TuHURA Biosciences.
TuHURA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's...